BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Y, Wang C, Liu Y, Tang L, Zheng M, Xu C, Song J, Meng X. miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn’s disease. Biochem Biophys Res Commun. 2013;438:133-139. [PMID: 23872065 DOI: 10.1016/j.bbrc.2013.07.040] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Li W, Chen T, Ren X, Zhu J, Hu F, Luo J, Xing L, Zhou H, Sun J, Jiang Q, Zhang Y, Xi Q. miR-146a-5p promotes epithelium regeneration against LPS-induced inflammatory injury via targeting TAB1/TAK1/NF-κB signaling pathway. Int J Biol Macromol 2022;221:1031-40. [PMID: 36096257 DOI: 10.1016/j.ijbiomac.2022.09.056] [Reference Citation Analysis]
2 Dong Y, Xu T, Xiao G, Hu Z, Chen J. Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease. Front Bioeng Biotechnol 2022;10:909591. [DOI: 10.3389/fbioe.2022.909591] [Reference Citation Analysis]
3 Vieujean S, Caron B, Haghnejad V, Jouzeau JY, Netter P, Heba AC, Ndiaye NC, Moulin D, Barreto G, Danese S, Peyrin-Biroulet L. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. Int J Mol Sci 2022;23:7611. [PMID: 35886959 DOI: 10.3390/ijms23147611] [Reference Citation Analysis]
4 Sun Z, Liu X, Lu M, Zhang X, Sun J. Serum-derived exosomes induce proinflammatory cytokines production in Cynoglossus semilaevis via miR-133-3p. Developmental & Comparative Immunology 2022. [DOI: 10.1016/j.dci.2022.104497] [Reference Citation Analysis]
5 Innocenti T, Bigagli E, Lynch EN, Galli A, Dragoni G. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing? Inflamm Bowel Dis 2022:izac122. [PMID: 35749310 DOI: 10.1093/ibd/izac122] [Reference Citation Analysis]
6 Changlin Z, Ying Z, Shuhua Z, Zeng J, Chi H. Research on the Protective Effect of MiR-185-3p Mediated by Huangqin-Tang Decoction (HQT) on the Epithelial Barrier Function of Ulcerative Colitis. Evid Based Complement Alternat Med 2021;2021:4775606. [PMID: 34970325 DOI: 10.1155/2021/4775606] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Stiegeler S, Mercurio K, Iancu MA, Corr SC. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability. Cells 2021;10:3358. [PMID: 34943865 DOI: 10.3390/cells10123358] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Suri K, Bubier JA, Wiles MV, Shultz LD, Amiji MM, Hosur V. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021;10:2204. [PMID: 34571853 DOI: 10.3390/cells10092204] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Jung H, Kim JS, Lee KH, Tizaoui K, Terrazzino S, Cargnin S, Smith L, Koyanagi A, Jacob L, Li H, Hong SH, Yon DK, Lee SW, Kim MS, Wasuwanich P, Karnsakul W, Shin JI, Kronbichler A. Roles of microRNAs in inflammatory bowel disease. Int J Biol Sci 2021;17:2112-23. [PMID: 34131410 DOI: 10.7150/ijbs.59904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee SA, Wang Y, Liu F, Riordan SM, Liu L, Zhang L. Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway. Infect Immun 2020;89:e00618-20. [PMID: 33046511 DOI: 10.1128/IAI.00618-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int J Mol Sci 2020;21:E7893. [PMID: 33114313 DOI: 10.3390/ijms21217893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
12 Bi K, Zhang X, Chen W, Diao H. MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review. Genes (Basel) 2020;11:E1075. [PMID: 32932716 DOI: 10.3390/genes11091075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
13 Li YY, Xu QW, Xu PY, Li WM. MSC-derived exosomal miR-34a/c-5p and miR-29b-3p improve intestinal barrier function by targeting the Snail/Claudins signaling pathway. Life Sci 2020;257:118017. [PMID: 32603821 DOI: 10.1016/j.lfs.2020.118017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wang G, Yuan J, Cai X, Xu Z, Wang J, Ocansey DKW, Yan Y, Qian H, Zhang X, Xu W, Mao F. HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clin Transl Med 2020;10:e113. [PMID: 32564521 DOI: 10.1002/ctm2.113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
15 Konstantinidis AΟ, Pardali D, Adamama-Moraitou KK, Gazouli M, Dovas CI, Legaki E, Brellou GD, Savvas I, Jergens AE, Rallis TS, Allenspach K. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 2020;16:69. [PMID: 32087719 DOI: 10.1186/s12917-020-02287-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
16 Gholami M, Larijani B, Zahedi Z, Mahmoudian F, Bahrami S, Omran SP, Saadatian Z, Hasani-Ranjbar S, Taslimi R, Bastami M, Amoli MM. Inflammation related miRNAs as an important player between obesity and cancers. J Diabetes Metab Disord 2019;18:675-92. [PMID: 31890692 DOI: 10.1007/s40200-019-00459-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Sakibuzzaman M, Moosa SA, Akhter M, Trisha IH, Talib KA. Identifying the Neurogenetic Framework of Crohn's Disease Through Investigative Analysis of the Nucleotide-binding Oligomerization Domain-containing Protein 2 Gene Mutation. Cureus 2019;11:e5680. [PMID: 31723489 DOI: 10.7759/cureus.5680] [Reference Citation Analysis]
18 Li Y, Yang N, Dong B, Yang J, Kou L, Qin Q. MicroRNA-122 promotes endothelial cell apoptosis by targeting XIAP: Therapeutic implication for atherosclerosis. Life Sci 2019;232:116590. [PMID: 31228514 DOI: 10.1016/j.lfs.2019.116590] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
19 Liu H, Li PW, Yang WQ, Mi H, Pan JL, Huang YC, Hou ZK, Hou QK, Luo Q, Liu FB. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. BMC Cancer. 2019;19:129. [PMID: 30736753 DOI: 10.1186/s12885-019-5328-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
20 Moein S, Vaghari-Tabari M, Qujeq D, Majidinia M, Nabavi SM, Yousefi B. MiRNAs and inflammatory bowel disease: An interesting new story. J Cell Physiol 2019;234:3277-93. [PMID: 30417350 DOI: 10.1002/jcp.27173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
21 Liu Z, Li C, Chen S, Lin H, Zhao H, Liu M, Weng J, Liu T, Li X, Lei C, Li C, Jiang Y, Moyer MP, Yin C, Zhou X. MicroRNA-21 increases the expression level of occludin through regulating ROCK1 in prevention of intestinal barrier dysfunction. J Cell Biochem 2019;120:4545-54. [PMID: 30302792 DOI: 10.1002/jcb.27742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
22 Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, Malapelle U, Qiu S, Nikolaou S, Barina A, Clerico G, Reginelli A, Giuliani A, Sciaudone G, Kontovounisios C, Brunese L, Trompetto M, Selvaggi F. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives. Gastroenterol Res Pract. 2018;2018:2397863. [PMID: 30008744 DOI: 10.1155/2018/2397863] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
23 Wang S, Huang Y, Zhou C, Wu H, Zhao J, Wu L, Zhao M, Zhang F, Liu H. The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease. Gastroenterol Res Pract 2018;2018:7565076. [PMID: 30046303 DOI: 10.1155/2018/7565076] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
24 Andaur R, Tapia JC, Moreno J, Soto L, Armisen R, Marcelain K. Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ionizing radiation in DLD-1 cells. Oncotarget 2018;9:26387-405. [PMID: 29899866 DOI: 10.18632/oncotarget.25405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Guo D, Ma J, Li T, Yan L. Up-regulation of miR-122 protects against neuronal cell death in ischemic stroke through the heat shock protein 70-dependent NF-κB pathway by targeting FOXO3. Exp Cell Res 2018;369:34-42. [PMID: 29715465 DOI: 10.1016/j.yexcr.2018.04.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
26 Latini A, Ciccacci C, Novelli G, Borgiani P. Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility. Immunol Res 2017;65:811-27. [PMID: 28741258 DOI: 10.1007/s12026-017-8937-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
27 Lin X, Zheng X, Fan D, Yao Q, Hu J, Lian L, Wu X, Lan P, He X. MicroRNA-143 Targets ATG2B to Inhibit Autophagy and Increase Inflammatory Responses in Crohn’s Disease. Inflammatory Bowel Diseases 2018;24:781-91. [DOI: 10.1093/ibd/izx075] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
28 Zhang Y, Tang L. Inhibition of breast cancer cell proliferation and tumorigenesis by long non-coding RNA RPPH1 down-regulation of miR-122 expression. Cancer Cell Int. 2017;17:109. [PMID: 29200969 DOI: 10.1186/s12935-017-0480-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
29 de Bruyn M, Vermeire S. NOD2 and bacterial recognition as therapeutic targets for Crohn’s disease. Expert Opinion on Therapeutic Targets 2017;21:1123-39. [DOI: 10.1080/14728222.2017.1397627] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
30 Ciccacci C, Politi C, Biancone L, Latini A, Novelli G, Calabrese E, Borgiani P. Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases. Mol Diagn Ther. 2017;21:107-114. [PMID: 27718165 DOI: 10.1007/s40291-016-0240-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
31 Cao B, Zhou X, Ma J, Zhou W, Yang W, Fan D, Hong L. Role of MiRNAs in Inflammatory Bowel Disease. Dig Dis Sci. 2017;62:1426-1438. [PMID: 28391412 DOI: 10.1007/s10620-017-4567-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
32 Chen Y, Salem M, Boyd M, Bornholdt J, Li Y, Coskun M, Seidelin JB, Sandelin A, Nielsen OH. Relation between NOD2 genotype and changes in innate signaling in Crohn's disease on mRNA and miRNA levels. NPJ Genom Med 2017;2:3. [PMID: 29263823 DOI: 10.1038/s41525-016-0001-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Belcheva A. MicroRNAs at the epicenter of intestinal homeostasis. Bioessays 2017;39. [PMID: 28155997 DOI: 10.1002/bies.201600200] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
34 Béres NJ, Szabó D, Kocsis D, Szűcs D, Kiss Z, Müller KE, Lendvai G, Kiss A, Arató A, Sziksz E, Vannay Á, Szabó AJ, Veres G. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:327-35. [PMID: 26752469 DOI: 10.1097/MIB.0000000000000687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
35 Pierdomenico M, Cesi V, Cucchiara S, Vitali R, Prete E, Costanzo M, Aloi M, Oliva S, Stronati L. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:315-326. [PMID: 26752466 DOI: 10.1097/MIB.0000000000000659] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
36 Guo Z, Gong J, Li Y, Gu L, Cao L, Wang Z, Zhu W, Li J. Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn's Disease. Nutrients 2016;8:E519. [PMID: 27556489 DOI: 10.3390/nu8080519] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
37 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
38 Li X, Nie J, Mei Q, Han WD. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma. World J Gastroenterol 2016; 22(23): 5317-5331 [PMID: 27340348 DOI: 10.3748/wjg.v22.i23.5317] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
39 Ye BD, McGovern DP. Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility. Expert Rev Clin Immunol 2016;12:1091-107. [PMID: 27156530 DOI: 10.1080/1744666X.2016.1184972] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
40 Lu Z, Liu R, Huang E, Chu Y. MicroRNAs: New regulators of IL-22. Cellular Immunology 2016;304-305:1-8. [DOI: 10.1016/j.cellimm.2016.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
41 Peck BC, Weiser M, Lee SE, Gipson GR, Iyer VB, Sartor RB, Herfarth HH, Long MD, Hansen JJ, Isaacs KL, Trembath DG, Rahbar R, Sadiq TS, Furey TS, Sethupathy P, Sheikh SZ. MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility. Inflamm Bowel Dis 2015;21:2178-87. [PMID: 26164662 DOI: 10.1097/MIB.0000000000000478] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
42 Adlakha YK, Saini N. MicroRNA: a connecting road between apoptosis and cholesterol metabolism. Tumour Biol 2016;37:8529-54. [PMID: 27105614 DOI: 10.1007/s13277-016-4988-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
43 Chi Y, Zhou D. MicroRNAs in colorectal carcinoma--from pathogenesis to therapy. J Exp Clin Cancer Res. 2016;35:43. [PMID: 26964533 DOI: 10.1186/s13046-016-0320-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 71] [Article Influence: 10.3] [Reference Citation Analysis]
44 Xu XM, Zhang HJ. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World J Gastroenterol 2016; 22(7): 2206-2218 [PMID: 26900285 DOI: 10.3748/wjg.v22.i7.2206] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
45 Hübenthal M, Hemmrich-Stanisak G, Degenhardt F, Szymczak S, Du Z, Elsharawy A, Keller A, Schreiber S, Franke A. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease. PLoS One. 2015;10:e0140155. [PMID: 26466382 DOI: 10.1371/journal.pone.0140155] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
46 Davis BK, Philipson C, Hontecillas R, Eden K, Bassaganya-Riera J, Allen IC. Emerging significance of NLRs in inflammatory bowel disease. Inflamm Bowel Dis 2014;20:2412-32. [PMID: 25153506 DOI: 10.1097/MIB.0000000000000151] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
47 Lamontagne J, Steel LF, Bouchard MJ. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World J Gastroenterol 2015; 21(24): 7375-7399 [PMID: 26139985 DOI: 10.3748/wjg.v21.i24.7375] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
48 Adams AT, Kennedy NA, Hansen R, Ventham NT, O’Leary KR, Drummond HE, Noble CL, El-Omar E, Russell RK, Wilson DC. Two-stage genome-wide methylation profiling in childhood-onset Crohn’s Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis. 2014;20:1784-1793. [PMID: 25144570 DOI: 10.1097/mib.0000000000000179] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
49 Dai X, Chen X, Chen Q, Shi L, Liang H, Zhou Z, Liu Q, Pang W, Hou D, Wang C. MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1. J Biol Chem. 2015;290:16099-16115. [PMID: 25931122 DOI: 10.1074/jbc.m115.659318] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
50 Kalla R, Ventham NT, Kennedy NA, Quintana JF, Nimmo ER, Buck AH, Satsangi J. MicroRNAs: new players in IBD. Gut 2015;64:504-17. [PMID: 25475103 DOI: 10.1136/gutjnl-2014-307891] [Cited by in Crossref: 165] [Cited by in F6Publishing: 159] [Article Influence: 23.6] [Reference Citation Analysis]
51 Lin WB, Liang MY, Chen GX, Yang X, Qin H, Yao JP, Feng KN, Wu ZK. MicroRNA profiling of the intestine during hypothermic circulatory arrest in swine. World J Gastroenterol 2015; 21(7): 2183-2190 [PMID: 25717255 DOI: 10.3748/wjg.v21.i7.2183] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
52 Yu X, Zhang J, Zheng X, Yang Y, Tang C. Interferon-γ in foam cell formation and progression of atherosclerosis. Clinica Chimica Acta 2015;441:33-43. [DOI: 10.1016/j.cca.2014.12.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
53 Chapman CG, Pekow J. The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol. 2015;8:4-22. [PMID: 25553076 DOI: 10.1177/1756283x14547360] [Cited by in Crossref: 99] [Cited by in F6Publishing: 96] [Article Influence: 14.1] [Reference Citation Analysis]
54 Stachurska A, Zorro MM, van der Sijde MR, Withoff S. Small and Long Regulatory RNAs in the Immune System and Immune Diseases. Front Immunol 2014;5:513. [PMID: 25368617 DOI: 10.3389/fimmu.2014.00513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
55 Fan HX, Tang H. Complex interactions between microRNAs and hepatitis B/C viruses. World J Gastroenterol 2014; 20(37): 13477-13492 [PMID: 25309078 DOI: 10.3748/wjg.v20.i37.13477] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
56 Stronati L, Pierdomenico M, Cesi V, Costanzo M, Aloi M, Oliva S, Civitelli F, Cucchiara S. MIR320 family regulates NOD2/CARD15: A new mechanism for controlling inflammation? Digestive and Liver Disease 2014;46:e82. [DOI: 10.1016/j.dld.2014.07.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
57 Naser SA, Abdelsalam A, Thanigachalam S, Naser AS, Alcedo K. Domino effect of hypomagnesemia on the innate immunity of Crohn’s disease patients. World J Diabetes 2014; 5(4): 527-535 [PMID: 25126398 DOI: 10.4239/wjd.v5.i4.527] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
58 Rigoli L, Caruso RA. Inflammatory bowel disease in pediatric and adolescent patients: A biomolecular and histopathological review. World J Gastroenterol 2014; 20(30): 10262-10278 [PMID: 25132743 DOI: 10.3748/wjg.v20.i30.10262] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
59 Igaz I, Szőnyi M, Varga P, Topa L. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases]. Orv Hetil 2014;155:487-91. [PMID: 24659741 DOI: 10.1556/OH.2014.29864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
60 Chen WX, Ren LH, Shi RH. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol 2014; 5(2): 63-70 [PMID: 24891977 DOI: 10.4291/wjgp.v5.i2.63] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 67] [Article Influence: 7.5] [Reference Citation Analysis]
61 Chen WX, Ren LH, Shi RH. Expression of miR-124 in active Crohn's disease and validation of aryl hydrocarbon receptor as its target gene. Shijie Huaren Xiaohua Zazhi 2014; 22(11): 1622-1627 [DOI: 10.11569/wcjd.v22.i11.1622] [Reference Citation Analysis]
62 Liew YJ, Aranda M, Carr A, Baumgarten S, Zoccola D, Tambutté S, Allemand D, Micklem G, Voolstra CR. Identification of microRNAs in the coral Stylophora pistillata. PLoS One 2014;9:e91101. [PMID: 24658574 DOI: 10.1371/journal.pone.0091101] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
63 Qiu Z, Dai Y. Roadmap of miR-122-related clinical application from bench to bedside. Expert Opin Investig Drugs 2014;23:347-55. [PMID: 24354366 DOI: 10.1517/13543784.2014.867327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]